BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22575017)

  • 21. Evaluation of Anticancer Activities of Novel Facile Synthesized Calix[n]arene Sulfonamide Analogs.
    Yilmaz B; Bayrac AT; Bayrakci M
    Appl Biochem Biotechnol; 2020 Apr; 190(4):1484-1497. PubMed ID: 31782087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of galectin-1 to breast cancer cells MCF7 induces apoptosis and inhibition of proliferation in vitro in a 2D- and 3D- cell culture model.
    Geiger P; Mayer B; Wiest I; Schulze S; Jeschke U; Weissenbacher T
    BMC Cancer; 2016 Nov; 16(1):870. PubMed ID: 27825375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.
    Nam K; Son SH; Oh S; Jeon D; Kim H; Noh DY; Kim S; Shin I
    Oncotarget; 2017 May; 8(22):35804-35823. PubMed ID: 28415760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Galectins in Tumors and in Clinical Immunotherapy.
    Chou FC; Chen HY; Kuo CC; Sytwu HK
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The alpha-galactomannan Davanat binds galectin-1 at a site different from the conventional galectin carbohydrate binding domain.
    Miller MC; Klyosov A; Mayo KH
    Glycobiology; 2009 Sep; 19(9):1034-45. PubMed ID: 19541770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of Galectin-1 Sensitizes HRAS-driven Tumor Growth to Rapamycin Treatment.
    Michael JV; Wurtzel JG; Goldfinger LE
    Anticancer Res; 2016 Oct; 36(10):5053-5061. PubMed ID: 27798864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered N-glycosylation in CD45 and regulatory roles of altered N-glycosylation in galectin-1-induced growth inhibition in human diffuse large B cell lymphoma.
    Suzuki O; Nozawa Y; Abe M
    Oncol Rep; 2005 Jan; 13(1):109-14. PubMed ID: 15583810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress.
    Ito K; Scott SA; Cutler S; Dong LF; Neuzil J; Blanchard H; Ralph SJ
    Angiogenesis; 2011 Sep; 14(3):293-307. PubMed ID: 21523436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting.
    Rapoport EM; André S; Kurmyshkina OV; Pochechueva TV; Severov VV; Pazynina GV; Gabius HJ; Bovin NV
    Glycobiology; 2008 Apr; 18(4):315-24. PubMed ID: 18256179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unique conformer selection of human growth-regulatory lectin galectin-1 for ganglioside GM1 versus bacterial toxins.
    Siebert HC; André S; Lu SY; Frank M; Kaltner H; van Kuik JA; Korchagina EY; Bovin N; Tajkhorshid E; Kaptein R; Vliegenthart JF; von der Lieth CW; Jiménez-Barbero J; Kopitz J; Gabius HJ
    Biochemistry; 2003 Dec; 42(50):14762-73. PubMed ID: 14674750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Galectin-1 Inhibitor Discovered through One-Bead Two-Compound Library Potentiates the Antitumor Effects of Paclitaxel
    Shih TC; Liu R; Fung G; Bhardwaj G; Ghosh PM; Lam KS
    Mol Cancer Ther; 2017 Jul; 16(7):1212-1223. PubMed ID: 28396365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMR-based insight into galectin-3 binding to endothelial cell adhesion molecule CD146: Evidence for noncanonical interactions with the lectin's CRD β-sandwich F-face.
    Zhang Z; Miller MC; Xu X; Song C; Zhang F; Zheng Y; Zhou Y; Tai G; Mayo KH
    Glycobiology; 2019 Jul; 29(8):608-618. PubMed ID: 31094416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of 1-benzyl-1H-benzimidazoles as galectin-1 mediated anticancer agents.
    Goud NS; Ghouse SM; Vishnu J; Komal D; Talla V; Alvala R; Pranay J; Kumar J; Qureshi IA; Alvala M
    Bioorg Chem; 2019 Aug; 89():103016. PubMed ID: 31185390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wedgelike glycodendrimers as inhibitors of binding of mammalian galectins to glycoproteins, lactose maxiclusters, and cell surface glycoconjugates.
    André S; Pieters RJ; Vrasidas I; Kaltner H; Kuwabara I; Liu FT; Liskamp RM; Gabius HJ
    Chembiochem; 2001 Nov; 2(11):822-30. PubMed ID: 11948868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiation-induced galectin-1 by endothelial cells: a promising molecular target for preferential drug delivery to the tumor vasculature.
    Upreti M; Jamshidi-Parsian A; Apana S; Berridge M; Fologea DA; Koonce NA; Henry RL; Griffin RJ
    J Mol Med (Berl); 2013 Apr; 91(4):497-506. PubMed ID: 23090010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calix[n]arene-based glycoclusters: bioactivity of thiourea-linked galactose/lactose moieties as inhibitors of binding of medically relevant lectins to a glycoprotein and cell-surface glycoconjugates and selectivity among human adhesion/growth-regulatory galectins.
    André S; Sansone F; Kaltner H; Casnati A; Kopitz J; Gabius HJ; Ungaro R
    Chembiochem; 2008 Jul; 9(10):1649-61. PubMed ID: 18509838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A carbohydrate-binding protein, Galectin-1, promotes proliferation of adult neural stem cells.
    Sakaguchi M; Shingo T; Shimazaki T; Okano HJ; Shiwa M; Ishibashi S; Oguro H; Ninomiya M; Kadoya T; Horie H; Shibuya A; Mizusawa H; Poirier F; Nakauchi H; Sawamoto K; Okano H
    Proc Natl Acad Sci U S A; 2006 May; 103(18):7112-7. PubMed ID: 16636291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Context-dependent multifunctionality of galectin-1: a challenge for defining the lectin as therapeutic target.
    Smetana K; André S; Kaltner H; Kopitz J; Gabius HJ
    Expert Opin Ther Targets; 2013 Apr; 17(4):379-92. PubMed ID: 23289445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lactulose as a novel template for anticancer drug development targeting galectins.
    Kishor C; Ross RL; Blanchard H
    Chem Biol Drug Des; 2018 Oct; 92(4):1801-1808. PubMed ID: 29888844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Galectin-1 Modulates the Survival and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Sensitivity in Human Hepatocellular Carcinoma Cells.
    Li J; Sun RR; Yu ZJ; Liang H; Shen S; Kan Q
    Cancer Biother Radiopharm; 2015 Oct; 30(8):336-41. PubMed ID: 26348206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.